Epilepsy drug displays wrong strength when scanned
The affected batches of Actavis-distributed primidone will display a strength of 250mg, rather than 50mg, says the MHRA
Batches of an epilepsy drug will display the wrong strength when scanned, the UK medicines watchdog has warned.
The drug's distributor Actavis UK had advised the Medicines and Healthcare products Regulatory Authority (MHRA) that three batches of Laboratoire SERB primidone 50mg will display a strength of 250mg when scanned, the watchdog said in a drug alert yesterday (November 9).
The correct strength is displayed on all parts of the drug’s cartons, and there is “no risk to product quality or patient safety” resulting from the error, the MHRA stressed.
One batch has already been distributed to pharmacies, while two are scheduled to be released. In order to prevent shortages, none of the batches are being recalled, it added.
Any stock queries should be directed to the Actavis customer services team on 0800 373573, while medical queries should be sent to [email protected].
Affected batches:
|
Batch Number |
Expiry Date |
Pack Size |
Livery |
First Distributed |
|
530689 |
November 2019 |
1 x 100 |
Laboratoire SERB |
October 6, 2015 |
|
531203 |
July 2020 |
1 x 100 |
Laboratoire SERB |
N/A |
|
531299 |
August 2020 |
1 x 100 |
Laboratoire SERB |
N/A |
Do you have any packs from the affected batches?
We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information
